Balyasny Asset Management Upped Its Tripadvisor (Call) (TRIP) Position by $23.35 Million; Medicines Co (MDCO) Shareholder Three Bays Capital LP Lowered Its Stake

June 8, 2018 - By Hazel Jackson

TripAdvisor, Inc. (NASDAQ:TRIP) Logo

Three Bays Capital Lp decreased its stake in Medicines Co (MDCO) by 32.15% based on its latest 2018Q1 regulatory filing with the SEC. Three Bays Capital Lp sold 821,774 shares as the company’s stock rose 4.51% while stock markets declined. The institutional investor held 1.73M shares of the major pharmaceuticals company at the end of 2018Q1, valued at $57.13 million, down from 2.56M at the end of the previous reported quarter. Three Bays Capital Lp who had been investing in Medicines Co for a number of months, seems to be less bullish one the $2.66 billion market cap company. The stock increased 0.33% or $0.12 during the last trading session, reaching $36.18. About 679,011 shares traded. The Medicines Company (NASDAQ:MDCO) has declined 16.45% since June 8, 2017 and is downtrending. It has underperformed by 29.02% the S&P500. Some Historical MDCO News: 09/04/2018 – SOUTH AFRICA’S NEW MEDICINES REGULATOR SAYS CONSIDERING ASKING PHARMA COMPANIES TO PAY “BACKLOG FEE” TO SPEED UP DRUG APPROVALS; 27/03/2018 – MEDICINES CO. NAMES CHRISTOPHER VISIOLI CFO AS O’CONNOR RETIRES; 28/03/2018 – European Medicines Agency (EMA) Accepts BioMarin’s Marketing Application for Pegvaliase MAA for Treatment of Phenylketonuria (P; 07/05/2018 – The Medicines Company Announces lnclisiran Data Showing Significant Reductions in Potentially Harmful Subtypes of Bad Cholesterol (Atherogenic Lipoproteins) Linked to Heart Attack and Stroke; 01/05/2018 – BioCryst Receives European Medicines Agency Approval for ALPIVABâ„¢ for the Treatment of Influenza; 29/03/2018 – SHIRE PLC ANNOUNCED EUROPEAN MEDICINES AGENCY HAS VALIDATED ITS MARKETING AUTHORIZATION APPLICATION FOR LANADELUMAB (SHP643); 25/04/2018 – MEDICINES CO 1Q LOSS/SHR CONT OPS $1.14; 27/03/2018 – Homology Medicines Announces Pricing of Initial Public Offering; 27/03/2018 – Medicines Co. Names Christopher Visioli Finance Chief, Effective Immediately; 06/04/2018 – DEERFIELD MGMT lll, L.P. REPORTS A 6.98 PCT STAKE IN HOMOLOGY MEDICINES AS OF APRIL 2, 2018 – SEC FILING

Dmitry Balyasny increased its stake in Tripadvisor Inc (Call) (TRIP) by 389.13% based on its latest 2018Q1 regulatory filing with the SEC. Balyasny Asset Management Llc bought 583,700 shares as the company’s stock rose 19.37% while stock markets declined. The hedge fund run by Dmitry Balyasny held 733,700 shares of the technology company at the end of 2018Q1, valued at $30.00M, up from 150,000 at the end of the previous reported quarter. Balyasny Asset Management Llc who had been investing in Tripadvisor Inc (Call) for a number of months, seems to be bullish on the $7.63B market cap company. The stock increased 0.11% or $0.06 during the last trading session, reaching $55.53. About 1.44 million shares traded. TripAdvisor, Inc. (NASDAQ:TRIP) has risen 24.26% since June 8, 2017 and is uptrending. It has outperformed by 11.69% the S&P500. Some Historical TRIP News: 09/04/2018 – Southwest Airlines Wins 2018 TripAdvisor Travelers’ Choice Awards For Airlines; 10/04/2018 – Liberty TripAdvisor Holdings to Conduct Quarterly Q&A Conference Call; 08/05/2018 – TripAdvisor 1Q EPS 4c; 08/05/2018 – TripAdvisor 1Q Rev $378M; 08/05/2018 – TripAdvisor ‘Incrementally Positive’ About 2018 Revenue Prospects; 15/05/2018 – TripAdvisor Names The 10 Hottest U.S. Destinations For Summer; 22/05/2018 – TripAdvisor Conference Call Set By Aliya Capital for May. 30; 09/04/2018 – Here are the top 10 airlines in the world as ranked by TripAdvisor customers; 20/04/2018 – TRIPADVISOR INC – TERMS OF ACQUISITION WILL NOT BE DISCLOSED; 14/05/2018 – TripAdvisor Presenting at JPMorgan Conference Tomorrow

Since December 18, 2017, it had 0 buys, and 4 selling transactions for $1.54 million activity. $1.12 million worth of TripAdvisor, Inc. (NASDAQ:TRIP) shares were sold by Halpin Dermot. TEUNISSEN ERNST 02494 also sold $378,280 worth of TripAdvisor, Inc. (NASDAQ:TRIP) on Tuesday, February 6. 728 shares were sold by Watson Noel Bertram, worth $35,002.

More news for TripAdvisor, Inc. (NASDAQ:TRIP) were recently published by: Fool.com, which released: “Why TripAdvisor Stock Gained 39% in May” on June 06, 2018. Seekingalpha.com‘s article titled: “TripAdvisor Looking To Turn Its Business Around” and published on June 01, 2018 is yet another important article.

Investors sentiment decreased to 1.05 in Q1 2018. Its down 0.19, from 1.24 in 2017Q4. It dropped, as 33 investors sold TRIP shares while 99 reduced holdings. 49 funds opened positions while 90 raised stakes. 119.17 million shares or 3.58% more from 115.06 million shares in 2017Q4 were reported. Credit Suisse Ag has invested 0.01% in TripAdvisor, Inc. (NASDAQ:TRIP). Howe Rusling reported 0% stake. Qs Ltd accumulated 1,662 shares. Hollencrest Capital Management has invested 0.06% in TripAdvisor, Inc. (NASDAQ:TRIP). Hartford Inv Mngmt Company owns 20,637 shares for 0.02% of their portfolio. Commerzbank Aktiengesellschaft Fi stated it has 97,948 shares or 0.04% of all its holdings. Quantitative Invest Management Ltd Liability Company holds 92,400 shares or 0.07% of its portfolio. Employees Retirement System Of Texas, Texas-based fund reported 101,000 shares. Fin Architects has invested 0.02% of its portfolio in TripAdvisor, Inc. (NASDAQ:TRIP). Chevy Chase Tru reported 91,702 shares. 82,195 are owned by Great Lakes Lc. Victory Management stated it has 0% of its portfolio in TripAdvisor, Inc. (NASDAQ:TRIP). Boothbay Fund Limited Co holds 10,652 shares or 0.05% of its portfolio. George Kaiser Family Foundation holds 29,655 shares. Natixis has 0% invested in TripAdvisor, Inc. (NASDAQ:TRIP) for 10,339 shares.

Balyasny Asset Management Llc, which manages about $14.49B and $23.94B US Long portfolio, decreased its stake in Dollar Tree Inc (NASDAQ:DLTR) by 1.29 million shares to 22,277 shares, valued at $2.11 million in 2018Q1, according to the filing. It also reduced its holding in Union Pac Corp (NYSE:UNP) by 178,176 shares in the quarter, leaving it with 135,196 shares, and cut its stake in Firstenergy Corp (Call) (NYSE:FE).

Among 33 analysts covering TripAdvisor LLC (NASDAQ:TRIP), 1 have Buy rating, 7 Sell and 25 Hold. Therefore 3% are positive. TripAdvisor LLC had 92 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was downgraded by Guggenheim on Friday, May 25 to “Sell”. Bank of America maintained the shares of TRIP in report on Wednesday, August 9 with “Sell” rating. Cowen & Co upgraded the stock to “Market Perform” rating in Wednesday, July 19 report. On Monday, February 22 the stock rating was downgraded by Stifel Nicolaus to “Sell”. The stock of TripAdvisor, Inc. (NASDAQ:TRIP) earned “Hold” rating by Deutsche Bank on Tuesday, May 8. The rating was maintained by RBC Capital Markets with “Sector Perform” on Friday, July 24. The firm earned “Hold” rating on Thursday, August 10 by Cowen & Co. Miller Tabak initiated the stock with “Hold” rating in Wednesday, January 18 report. The stock of TripAdvisor, Inc. (NASDAQ:TRIP) earned “Neutral” rating by Macquarie Research on Tuesday, October 27. The rating was maintained by Deutsche Bank with “Buy” on Friday, July 24.

Among 12 analysts covering The Medicines Co (NASDAQ:MDCO), 12 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. The Medicines Co had 38 analyst reports since August 28, 2015 according to SRatingsIntel. The stock has “Buy” rating by Cowen & Co on Wednesday, August 9. The firm earned “Buy” rating on Saturday, August 29 by JP Morgan. H.C. Wainwright initiated the stock with “Buy” rating in Monday, December 5 report. The stock has “Buy” rating by H.C. Wainwright on Tuesday, July 25. The company was maintained on Monday, August 28 by Oppenheimer. The firm has “Neutral” rating by Citigroup given on Monday, August 14. The stock of The Medicines Company (NASDAQ:MDCO) earned “Buy” rating by Jefferies on Monday, June 26. The rating was maintained by Citigroup with “Neutral” on Monday, July 17. Oppenheimer maintained it with “Hold” rating and $5000 target in Thursday, August 10 report. The firm has “Hold” rating by Oppenheimer given on Thursday, February 22.

More recent The Medicines Company (NASDAQ:MDCO) news were published by: Seekingalpha.com which released: “Rounds Report: Melinta Rallied While Novavax Experienced Significant Insider Purchases” on June 06, 2018. Also Seekingalpha.com published the news titled: “Premarket analyst action – healthcare” on June 07, 2018. Seekingalpha.com‘s news article titled: “Rounds Report: Melinta Rallied While The FDA Approved OsteoDetect” with publication date: May 26, 2018 was also an interesting one.

Three Bays Capital Lp, which manages about $1.36B and $1.44 billion US Long portfolio, upped its stake in Hca Healthcare Inc (NYSE:HCA) by 9,300 shares to 522,277 shares, valued at $50.66 million in 2018Q1, according to the filing. It also increased its holding in Gray Television Inc (NYSE:GTN) by 1.21 million shares in the quarter, for a total of 1.30 million shares, and has risen its stake in Intercontinental Exchange Inc (NYSE:ICE).

Since December 15, 2017, it had 0 buys, and 4 insider sales for $4.77 million activity. On Friday, May 25 Spigelman Melvin K sold $241,500 worth of The Medicines Company (NASDAQ:MDCO) or 7,500 shares. KESSLER ARMIN M had sold 20,000 shares worth $574,200. MEANWELL CLIVE sold 136,250 shares worth $3.71 million.

Analysts await The Medicines Company (NASDAQ:MDCO) to report earnings on August, 8. They expect $-1.00 earnings per share, up 81.88% or $4.52 from last year’s $-5.52 per share. After $-0.80 actual earnings per share reported by The Medicines Company for the previous quarter, Wall Street now forecasts 25.00% negative EPS growth.

Investors sentiment decreased to 1.02 in Q1 2018. Its down 0.23, from 1.25 in 2017Q4. It fall, as 30 investors sold MDCO shares while 51 reduced holdings. 25 funds opened positions while 58 raised stakes. 91.05 million shares or 1.80% more from 89.44 million shares in 2017Q4 were reported. New York-based Bridger Management Llc has invested 5.31% in The Medicines Company (NASDAQ:MDCO). Millennium Management owns 7,141 shares. Royal Bankshares Of Canada accumulated 290 shares. Franklin Resource invested in 0.03% or 1.96 million shares. Old West Investment Mgmt Ltd Liability Co reported 0.13% stake. Atlantic Tru Gp Ltd Liability Co reported 0% of its portfolio in The Medicines Company (NASDAQ:MDCO). Raymond James & invested 0% of its portfolio in The Medicines Company (NASDAQ:MDCO). Macquarie Group holds 1.15 million shares. Shelton Cap Mngmt stated it has 6,505 shares. Teacher Retirement Sys Of Texas holds 16,143 shares. Qs Investors Ltd Com reported 0% in The Medicines Company (NASDAQ:MDCO). Granahan Investment Mgmt Inc Ma accumulated 1.14% or 480,186 shares. Pnc Services accumulated 10,545 shares or 0% of the stock. Connecticut-based Sarissa Capital LP has invested 14.65% in The Medicines Company (NASDAQ:MDCO). Savings Bank Of America De has invested 0% in The Medicines Company (NASDAQ:MDCO).

The Medicines Company (NASDAQ:MDCO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>